Does METOPROLOL Cause Neoplasm malignant? 67 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Neoplasm malignant have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.2% of all adverse event reports for METOPROLOL.
67
Reports of Neoplasm malignant with METOPROLOL
0.2%
of all METOPROLOL reports
12
Deaths
26
Hospitalizations
How Dangerous Is Neoplasm malignant From METOPROLOL?
Of the 67 reports, 12 (17.9%) resulted in death, 26 (38.8%) required hospitalization, and 3 (4.5%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which METOPROLOL Alternatives Have Lower Neoplasm malignant Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE